21590 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Cancerous Disease Modifying Antibodies
#302Cancerous Disease Modifying Antibodies
#303IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS
#304CANCEROUS DISEASE MODIFYING ANTIBODIES
#305METHODS OF TREATING PROSTATE CANCER WITH ANTI-PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES
#306Antibodies and immunoconjugates and uses therefor
#307Chimeric antibody against tumor associated antigens and its use in diagnosing tumors
#308SELECTIVE TARGETING OF TUMOR VASCULATURE USING RADIOLABELLED ANTIBODY MOLECULES
#309CANCEROUS DISEASE MODIFYING ANTIBODIES
#310CANCEROUS DISEASE MODIFYING ANTIBODIES
#311Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#312COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#313Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
#314Cytotoxicity mediation of cells evidencing surface expression of CD63
#315Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#316Cytotoxicity mediation of cells evidencing surface expression of MCSP
#317Antibody therapy
#318Cancerous Disease modifying antibodies
#319Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof
#320Cytotoxicity mediation of cells evidencing surface expression of CD9
#321Carbonic anhydrase IX (G250) anitbodies
#322Cytotoxicity mediation of cells evidencing surface expression of CD63
#323MODIFIED ANTIBODIES AND METHODS OF USE
#324Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#325METHODS FOR DETECTING PATHOLOGICAL SITES
#326Cancerous disease modifying antibodies
#327Cancerous disease modifying antibodies
#328Cytotoxicity mediation of cells evidencing surface expression of MCSP
#329Cancerous disease modifying antibodies
#330Cancerous disease modifying antibodies
#331RG1 antibodies and uses thereof
#332THERAPEUTIC USE OF ANTI-TF-ANTIGEN ANTIBODY
#333Chimeric, human and humanized anti-CSAp monoclonal antibodies
#334Cancerous disease modifying antibodies
#335Cancerous Disease Modifying Antibodies
#336Cancerous Disease Modifying Antibodies
#337Cancerous disease modifying antibodies
#338Ovr110 antibody compositions and methods of use
#339Chimeric, human and humanized anti-CSAP monoclonal antibodies
#340Chimeric, human and humanized anti-CSAp monoclonal antibodies
#341RG1 antibodies and uses thereof
#342Cancerous disease modifying antibodies
#343Cancerous disease modifying antibodies
#344Cancerous disease modifying antibodies
#345Chimeric, human and humanized anti-CSAP monoclonal antibodies
#346Variants of humanized anti-carcinoma MAb CC49
#347Cytotoxicity mediation of cells evidencing surface expression of CD63
#348TAG-72 specific C2 domain deleted antibodies
#349Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
#350RS7 antibodies
#351Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#352Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#353ANTIBODY THERAPY
#354Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#355Cancerous disease modifying antibodies
#356Cancerous disease modifying antibodies
#357Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#358Compositions and methods for cancer immunotherapy
#359Radiotherapeutic high specific activity tin-117m and methods of use
#360Polynucleotides encoding novel isoforms of IGSF9
#361Ligands to radiation-induced molecules
#362Methods of inducing an immune response
#363Methods of inducing an immune response
#364Methods of inducing an immune response
#365Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
#366Cytotoxicity mediation of cells evidencing surface expression of CD63
#367Antibodies and related molecules that bind to 161P2F10B proteins
#368Cytotoxicity mediation of cells evidencing surface expression of CD63
#369Combination therapy in the treatment of cancer
#370Tumor-specific recognition molecules
#371Cytotoxicity mediation of cells evidencing surface expression of CD63
#372VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment
#373Agents for the diagnosis and treatment of tumors that expose alerted proteins on the cell surface
#374Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors
#375Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#376Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
#377Method of treating tumors
#378Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
#379Method of affecting a function of or ablating a non-malignant cell
#380Antibody recognizing antibody
#381Radiolabeled antibodies and peptides for treatment of tumors
#382Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
#383Novel antibody conjugates reactive with human carcinomas
#384Therapeutic use of anti-TF-Antigen antibody
#385Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
#386Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#387Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#388Methods to inhibit cell growth
#389Method for preparing conjugates of proteins and chelating agents
#390Variants of humanized anti-carcinoma monoclonal antibody CC49
#391Uses of monoclonal antibody 8H9
#392Chimeric, human and humanized anti-CSAp monoclonal antibodies
#393Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
#394Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA
#395Selective targeting of tumor vasculature using radiolabelled antibody molecules
#396Cytotoxicity mediation of cells evidencing surface expression of MCSP
#397Bivalent targeting of cell surfaces
#398RG1 antibodies and uses thereof
#399Cancerous disease modifying antibodies
#400Radioconjugates directed to MHC-complexed antigens in cancer